GC
COYA icon

Gilbert & Cook’s Coya Therapeutics COYA Stock Holding History

Gilbert & Cook’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,000
Closed -$60.6K – 218
2024
Q2 		$60.6K Buy
+10,000
New +$80.3K 0.01% 210

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gilbert & Cook's COYA Position: Q3 2024 in Review

Gilbert & Cook sold out of Coya Therapeutics (COYA) in Q3 2024, closing a stake of 10,000 shares — an estimated $60.6K sold.

Gilbert & Cook first reported a position in COYA in Q2 2024 and held it in 1 quarter. The position peaked at $60.6K in Q2 2024. 19 funds tracked by Wall St. Rank hold COYA as of Q3 2024.

  • Gilbert & Cook reported no remaining Coya Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Gilbert & Cook sold 10,000 Coya Therapeutics shares in Q3 2024, an estimated $60.6K.
  • Gilbert & Cook first reported a position in Coya Therapeutics in Q2 2024 and held it in 1 quarter.
  • Gilbert & Cook's Coya Therapeutics position peaked at $60.6K in Q2 2024.
  • 19 funds tracked by Wall St. Rank held Coya Therapeutics as of Q3 2024.

Based on Gilbert & Cook's 13F filing for Q3 2024, filed 7 Nov 2024.